Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.16B | 3.22B | 3.36B | 17.81B | 10.78B |
Gross Profit | 743.65M | 782.27M | 717.73M | 2.16B | 1.72B |
EBITDA | 117.19M | 71.11M | 13.32M | 30.35M | 795.39M |
Net Income | 96.88M | 86.62M | 33.67M | 574.55M | 403.58M |
Balance Sheet | |||||
Total Assets | 6.08B | 6.42B | 8.01B | 10.42B | 8.44B |
Cash, Cash Equivalents and Short-Term Investments | 594.38M | 854.25M | 1.09B | 783.35M | 565.30M |
Total Debt | 1.24B | 1.44B | 2.22B | 2.28B | 1.72B |
Total Liabilities | 2.26B | 2.50B | 3.55B | 5.69B | 4.21B |
Stockholders Equity | 3.79B | 3.93B | 4.41B | 3.80B | 3.41B |
Cash Flow | |||||
Free Cash Flow | 46.34M | 204.68M | 186.57M | -254.15M | 32.04M |
Operating Cash Flow | 86.55M | 236.54M | 373.01M | 266.37M | 222.20M |
Investing Cash Flow | 226.06M | 655.38M | 68.70M | -316.56M | -184.40M |
Financing Cash Flow | -319.25M | -1.34B | -97.68M | 230.99M | -520.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | HK$574.62M | 4.95 | 20.67% | 20.00% | 25.95% | 44.16% | |
74 Outperform | $939.73M | 9.74 | 2.51% | 12.94% | -1.70% | 12.53% | |
62 Neutral | $10.14B | 9.96 | 0.09% | 2.90% | 2.26% | -33.42% | |
56 Neutral | HK$649.23M | ― | -8.95% | ― | -3.09% | -480.17% | |
54 Neutral | HK$811.61M | 55.38 | -1.16% | 6.50% | 2.49% | -171.78% | |
52 Neutral | HK$388.35M | ― | -6.09% | ― | -30.21% | -12.78% | |
41 Neutral | HK$152.00M | ― | -11.66% | ― | -31.49% | 28.61% |
Yip’s Chemical Holdings Limited has announced a supplemental update to its Annual Report for the year ended 31 December 2024. The company repurchased 10,024,000 shares at a cost of HK$14,833,500, which are held as treasury shares. The decision on whether to cancel or sell these shares will depend on market conditions and the company’s capital management needs. This move reflects the company’s strategic approach to capital management and compliance with relevant regulations.
Yip’s Chemical Holdings Limited has updated the terms of reference for its Nomination Committee, emphasizing the importance of board diversity and strategic alignment. The committee is tasked with reviewing the board’s structure and composition, ensuring a diverse and skilled board to support the company’s corporate strategy.
Yip’s Chemical Holdings Limited has announced a change in its board of directors with the appointment of Ms. Yau as an independent non-executive director, effective March 22, 2024. Ms. Yau has confirmed her independence, having no financial or other interests in the company’s business or connections with its core connected persons. This change is part of the company’s ongoing efforts to maintain a diverse and independent board, which is crucial for its governance and strategic decision-making.
Yip’s Chemical Holdings Limited successfully held its Annual General Meeting on June 5, 2025, where all proposed resolutions were passed with significant support. Key resolutions included the adoption of financial statements, declaration of a final dividend, reappointment of auditors, and re-election of directors, demonstrating strong shareholder confidence and strategic continuity.
Yip’s Chemical Holdings Limited has announced its upcoming Annual General Meeting (AGM) scheduled for June 5, 2025, in Hong Kong. Key agenda items include the adoption of financial statements, declaration of a final dividend, reappointment of Deloitte Touche Tohmatsu as auditors, and re-election of board members. Additionally, the company seeks shareholder approval for a general mandate to issue additional shares, which could impact its market operations and shareholder value.